Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218

Detalles Bibliográficos
Autores principales: Jongen, Johannes, Schneider, Jessica, Kahlke, Volker, Laubert, Tilman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104443/
https://www.ncbi.nlm.nih.gov/pubmed/35566621
http://dx.doi.org/10.3390/jcm11092495
_version_ 1784707795784826880
author Jongen, Johannes
Schneider, Jessica
Kahlke, Volker
Laubert, Tilman
author_facet Jongen, Johannes
Schneider, Jessica
Kahlke, Volker
Laubert, Tilman
author_sort Jongen, Johannes
collection PubMed
description
format Online
Article
Text
id pubmed-9104443
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91044432022-05-14 Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218 Jongen, Johannes Schneider, Jessica Kahlke, Volker Laubert, Tilman J Clin Med Comment MDPI 2022-04-29 /pmc/articles/PMC9104443/ /pubmed/35566621 http://dx.doi.org/10.3390/jcm11092495 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Comment
Jongen, Johannes
Schneider, Jessica
Kahlke, Volker
Laubert, Tilman
Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
title Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
title_full Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
title_fullStr Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
title_full_unstemmed Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
title_short Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
title_sort comment on pata et al. sclerobanding (combined rubber band ligation with 3% polidocanol foam sclerotherapy) for the treatment of second- and third-degree hemorrhoidal disease: feasibility and short-term outcomes. j. clin. med. 2022, 11, 218
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104443/
https://www.ncbi.nlm.nih.gov/pubmed/35566621
http://dx.doi.org/10.3390/jcm11092495
work_keys_str_mv AT jongenjohannes commentonpataetalsclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomesjclinmed202211218
AT schneiderjessica commentonpataetalsclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomesjclinmed202211218
AT kahlkevolker commentonpataetalsclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomesjclinmed202211218
AT lauberttilman commentonpataetalsclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomesjclinmed202211218

Ejemplares similares